πŸ‡ΊπŸ‡Έ FDA
Patent

US 11033623

Magnetic stem cell therapy for lesions

granted A61KA61K2035/124A61K35/28

Quick answer

US patent 11033623 (Magnetic stem cell therapy for lesions) held by GREINER BIO-ONE NORTH AMERICA, INC. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GREINER BIO-ONE NORTH AMERICA, INC.
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2035/124, A61K35/28, A61K35/34, A61K35/35